about uscontact usfor employeessite map
ResearchTrainingFundingClinicsCalendarResources

Funding

CFAR Emerging Opportunity Grant Program

The UW/FHCRC Center for AIDS Research (CFAR) announces the availability of funds to support Emerging Opportunity Grants related to human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).

Purpose

To provide funding within 1-2 months after applying, for time-sensitive HIV/AIDS-related research projects that take advantage of recent developments in a field, new technologies, or that will provide an important new resource or technology to the UW HIV/AIDS research community. The intent of these grants is to provide short-term, start-up funds, to test hypotheses, and to generate sufficient data for subsequent applications for other funds. Awardees should plan to apply for other funding, if results warrant. Proposed projects must be distinct from ongoing work. The award period for this grant is a maximum of one year.

Eligibility

Must be active investigators (faculty or trainees) at UW or a UW-affiliated institution, e.g. Fred Hutchinson Cancer Research Center, Seattle Biomedical Research Institute, Children's Hospital and Regional Medical Center, or affiliated international institution (must have collaborative relationship with UW faculty or UW affiliate faculty).

Types of Projects

HIV/AIDS-related research is defined broadly and includes basic science, clinical, behavioral, epidemiological, and health services research. Please note that we cannot fund clinical trials, except for behavioral interventions with a Data Safety Monitoring Plan or Data Safety Monitoring Board (as defined by NIMH policy).

Funding Available

Up to $25,000 direct costs per award, for a maximum of one year.

Pre-Submission Requirements

Potential applicants should contact Ann Collier, MD, (206-744-3293, acollier@u.washington.edu) to discuss their proposal BEFORE preparing an application.

UW applicants do not need departmental, school, or Office of Sponsored Programs signatures. Applicants from other institutions should prepare and submit a NIH 398 face page, with concurrence from their institution's business official; and consult with the CFAR Administrative Director, Susan Mello, at spmello@u.washington.edu or 206-744-2238, prior to preparing an application.

Pre-Award Requirements

Human Subjects and Animal Care Approvals: Animal Care and Institutional Review Board approvals, if applicable, must be obtained prior to receipt of an award, but are not required to submit an application. Proposals involving either international sites or clinical research above minimal risk will require additional clearance from NIH prior to receipt of an award, which includes IRB approval from all participating sites and human subjects training certification for all key personnel.

Post-Award Requirements

  1. Prior to funding, a copy of all Institutional Biohazard, Animal Care and IRB approvals must be forwarded to the CFAR Administrative Director. If the project involves human subjects and the institutional IRB has deemed the study "greater than minimal risk", the awardee must submit a Clinical Research Checklist to the CFAR Administrative Director before funding is released. If the project is being conducted overseas, prior approval from NIH is required prior to commencement of the study.
  2. Awardees will be required to submit progress reports to the CFAR and make an oral presentation at the annual UW AIDS & STD Research Symposium.
  3. CFAR support must be acknowledged in all publications derived from CFAR funding.
  4. In the event that pending other support is funded which overlaps with or reduces your effort on this CFAR project, you must notify the CFAR Administrative Director. Your funding status will be reviewed and if it is determined that you are unable to meet the specific aims of your CFAR proposal, the CFAR award will be revoked.
  5. After project is completed, be available to provide information about publications, collaborations, and future grants related to your CFAR project.

Application Instructions

After completing all pre-submission requirements, submit the following in one MS Word file by December 1, 2008 to cfarawds@u.washington.edu:

  1. Cover letter describing the title of the project, applicant contact information (UW box number or address, telephone and fax numbers, and email address.
  2. Research Plan (2-3 pages). Emphasize the rationale, why the work is time-sensitive and important in the context of HIV/AIDS, and include a description of the experimental plan).
  3. NIH 398 detailed budget and budget justification.
  4. NIH-style biographical sketch(es) of key personnel.
  5. Letters of support from collaborators essential to the success of proposed project.